Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
MPW Medical Properties Trust Inc
PSXP Phillips 66 Partners LP
EQ Equillium Inc
TSLA Tesla Inc
OPK OPKO Health Inc
PNW Pinnacle West Capital Corp
ROLL RBC Bearings Inc
GLAD Gladstone Capital Corp
PAC Grupo Aeroportuario del Pacifico SAB de CV
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$58.15
Day's Change
-0.38 (-0.65%)
Bid
--
Ask
--
B/A Size
--
Day's High
58.58
Day's Low
57.18
Volume
(Average)
Volume:
11,871,686

10-day average volume:
12,568,205
11,871,686
  • Prev Close
    58.53
  • Today's Open
    57.79
  • Day's Range
    57.18-58.58
  • Avg Vol (10-day)
    12.6M
  • Last (time)
    4:00p ET 10/30/20
  • Last (size)
    10
  • 52-Wk Range
    57.04 - 85.97
    LowHigh
  • (03/19/20 - 10/29/20)
    1.95%
  • 37.6%
  • Market Cap
    72.9B
  • Shares Outstanding
    1.3B
  • 0.96
  • 60.42x
  • $2.72/4.65%
  • Ex-dividend Date
    12/14/20
  • Dividend Pay Date
    12/30/20
  • 0.5
  • 79.84
  • (% of float 10/15/20)
    1.64

Latest News

October 29, 2020
4:59 pm ET
PR Newswire
4:39 pm ET
Zacks
12:51 pm ET
MarketWatch
10:26 am ET
MarketWatch
8:32 am ET
MarketWatch
October 28, 2020
4:14 pm ET
MarketWatch
2:31 pm ET
Accesswire
1:02 pm ET
BusinessWire
1:01 pm ET
BusinessWire
9:48 am ET
MarketWatch
7:34 am ET
MarketWatch
October 27, 2020
8:44 am ET
MarketWatch
October 26, 2020
9:31 am ET
PR Newswire
8:00 am ET
BusinessWire
October 23, 2020
9:15 am ET
BusinessWire
8:30 am ET
PR Newswire
8:30 am ET
BusinessWire
6:21 am ET
MarketWatch
October 22, 2020
4:37 pm ET
MarketWatch
4:02 pm ET
BusinessWire
12:15 pm ET
BusinessWire
11:42 am ET
Globe Newswire
8:30 am ET
PR Newswire
October 21, 2020
3:25 pm ET
MarketWatch
10:37 am ET
MarketWatch
7:01 am ET
BusinessWire
October 19, 2020
8:30 am ET
BusinessWire
October 17, 2020
6:30 pm ET
MarketWatch
October 16, 2020
8:33 am ET
MarketWatch
7:28 am ET
BusinessWire
6:35 am ET
MarketWatch
October 15, 2020
4:25 pm ET
MarketWatch
October 14, 2020
4:01 pm ET
BusinessWire
8:30 am ET
BusinessWire
7:32 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.